Figure 2: Survival for patients stratified by the serum GP88 cut off of ≤55 and >55 ng/ml.
Kaplan-Meier analysis of survival of MBC patients who were stratified into two groups based on their serum GP88 values. Hatched blue line (LL) corresponded to patients (74 patients) whose serum GP88 remained below or equal to 55 ng/ml. Solid red line (HH) corresponded to patients (17 patients) with serum GP88 levels remaining high > 55 ng/ml.